|
Dr. Alan B. Glassberg is a Venture Partner and member of the Scientific Advisory Board of Bay City Capital, a firm that manages investment funds in the life sciences industry. He has been associated with Bay City Capital since 2006. Dr. Glassberg served as Chief Medical Officer of Poniard Pharmaceuticals Inc. from August 2006 to March 2007, and he currently serves as a consultant to Poniard and as a member of its Clinical Advisory Board. Dr. Glassberg was Associate Director of Clinical Care and Director of General Oncology at the University of California San Francisco Cancer Center and Director of Hematology and Medical Oncology at Mount Zion Medical Center in San Francisco until June 2006. He received his M.D. from the Medical University of South Carolina in Charleston. Dr. Glassberg began serving as a Director of IDEC Pharmaceuticals in 1997. | 